Joshua Boger, Ph.D
Founder & former CEO
Joshua Boger is the founder of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and retired as CEO in May 2009. Prior to founding Vertex in 1989, he worked for more than a decade in pharmaceutical research at Merck, where he developed an international reputation as a leader in the application of computer modeling to the chemistry of drug design and was a pioneer in the use of structure-based rational drug design as the basis for drug discovery programs. He holds a bachelor of arts in Chemistry and Philosophy from Wesleyan University (Connecticut) and a master's and doctorate degrees in Chemistry from Harvard University. He is the author of over 50 scientific publications, holds 31 issued U.S. patents in pharmaceutical discovery and development, and has lectured widely in the United States, in Europe and in Asia on various aspects of drug discovery, development and commercialization.
He is Chairman of the Board of Trustees at Wesleyan University (Middletown, CT), Chairman of the New England Healthcare Institute (a non-profit, healthcare-policy research organization based in Cambridge. MA), Vice-Chair of the Board of Fellows of the Harvard Medical School, Co-Chairman of the Progressive Business Leaders Network (a non-profit, non-partisan business organization) and Chair of the Board of the Celebrity Series (Boston’s premier performing arts series).

No comments:
Post a Comment